Enhancing Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.96M Hold
15,600
2.72% 9
2026
Q1
$3.81M Hold
15,600
2.83% 9
2025
Q4
$3.23M Hold
15,600
2.31% 12
2025
Q3
$2.89M Hold
15,600
2.12% 16
2025
Q2
$2.38M Hold
15,600
1.82% 16
2025
Q1
$2.59M Hold
15,600
2.07% 14
2024
Q4
$2.26M Buy
+15,600
New +$2.42M 1.8% 17
2022
Q3
$2.55M Hold
15,925
3.16% 7
2022
Q2
$2.83M Sell
15,925
-8
-0.1% -$1.43K 3.38% 7
2022
Q1
$2.82M Hold
15,933
3.02% 6
2021
Q4
$2.73M Buy
+15,933
New +$2.61M 2.96% 4

Other funds holding JNJ

Enhancing Capital's JNJ Position: Q2 2026 in Review

Enhancing Capital held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 15,600 shares worth $3.96M. The position accounts for 2.72% of the portfolio, ranked #9.

Enhancing Capital first reported a position in JNJ in Q4 2021 and has held it in 11 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Enhancing Capital held 15,600 shares of Johnson & Johnson worth $3.96M as of Q2 2026.
  • Enhancing Capital left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 2.72% of Enhancing Capital's portfolio in Q2 2026, its #9 holding.
  • Enhancing Capital first reported a position in Johnson & Johnson in Q4 2021 and has held it in 11 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Enhancing Capital's 13F filing for Q2 2026, filed 11 Aug 2026.